UCB appoints CCA to push Keppra

UCB Pharma has appointed Chandler Chicco Agency (CCA) to handle global PR for epilepsy drug Keppra.

The PR programme will include third-party group relationships and patient advocacy; CCA will also promote ad hoc financial announcements. The account was held for four years by Ketchum, which retains its UK contract.

CCA has also been hired to run UK comms for UCB’s oxybutynin patch, a transdermal delivery system for overactive bladders.

CCA reports to Brussels-based UCB head of pharma comms Margaret Morgan and its UK headquarters.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in